- Interpretable dimensionality reduction of single cell transcriptome data with deep generative models.
- The RNA-binding protein YBX1 regulates epidermal progenitors at a posttranscriptional level.
- Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers.
- Identification of cancer-associated missense mutations in hace1 that impair cell growth control and Rac1 ubiquitylation.
January 12, 2015
Dr. Mardis joined The Genome Institute at Washington University, St. Louis, MO, in 1993. As Director of Technology Development, she helped create methods and automation pipelines for sequencing the human genome. Dr. Mardis has research interests in the application of next-generation sequencing to characterize cancer genomes and transcriptomes, and using these data to support therapeutic decision-making. […]
November 1, 2010
Richard T. Israels QC Memorial Distinguished Lecture Presents: “Evolution of the Cancer Genome” by Michael R Stratton FRS Director, Wellcome Trust Sanger Institute Joint Head, Cancer Genome Project Professor of Cancer Genetics Institute of Cancer Research Cambridge, England Monday November 15th, 2010, 12pm to 1pm Gordon & Leslie Diamond Family Theatre 675 W.10th Ave, Vancouver, […]